Matthew Brams

1.3k citations

40 papers · 995 indexed · h-index 20

Impact in

Psychiatry and Mental health top 1%
- Attention Deficit Hyperactivity Disorder
- Bipolar Disorder and Treatment
Cognitive Neuroscience top 5%
- Neural and Behavioral Psychology Studies
- Autism Spectrum Disorder Research
- Functional Brain Connectivity Studies

Papers in ⓘ

Psychiatry and Mental health 37
- Attention Deficit Hyperactivity Disorder 35
- Bipolar Disorder and Treatment 18
Cognitive Neuroscience 11
- Autism Spectrum Disorder Research 5
- Functional Brain Connectivity Studies 4
- Neural and Behavioral Psychology Studies 3

Co-authors: Ann Childress (17 shared papers)Maria Gasior (6 shared papers)Robert L. Findling (5 shared papers)Rafael Muniz (7 shared papers)Joseph Gao (4 shared papers)Timothy Wigal (5 shared papers)Alice R. Mao (6 shared papers)Sharon B. Wigal (4 shared papers)
Journals: Journal of Child and Adolescent Psychopharmacology (11 papers)Journal of the American Academy of Child & Adolescent Psychiatry (6 papers)Journal of Attention Disorders (2 papers)Current Medical Research and Opinion (2 papers)The Journal of Clinical Psychiatry (2 papers)
Partner nations: United States Switzerland Belgium

In The Last Decade

Matthew Brams

40 papers receiving 903 citations

Peers

Countries citing papers authored by Matthew Brams

Since Specialization

Citations

This map shows the geographic impact of Matthew Brams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Brams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Brams more than expected).

Fields of papers citing papers by Matthew Brams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Brams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Brams. The network helps show where Matthew Brams may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew Brams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Brams Line = papers co-authored together Matthew Brams links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design Behavioral and Brain Functions ·Timothy Wigal, Matthew Brams, Maria Gasior, Joseph Gao, Liza Squires, John Giblin, (unknown)	2010	117
2	Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD PEDIATRICS ·Scott H. Kollins, Rakesh K. Jain, Matthew Brams, Scott Segal, Robert L. Findling, Sharon B. Wigal, Moise Khayrallah	2011	98
3	A Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity Disorder Journal of the American Academy of Child & Adolescent Psychiatry ·Timothy E. Wilens, Oscar G. Bukstein, Matthew Brams, Andrew J. Cutler, Ann Childress, Thomas A. Rugino, A. G. Lyne, Kara Grannis, Sharon Youcha	2011	82
4	Lurasidone for the Treatment of Irritability Associated with Autistic Disorder Journal of Autism and Developmental Disorders ·Antony Loebel, Matthew Brams, Robert Goldman, Robert Silva, David Hernández‐Moreno, Ling Deng, Raymond Mankoski, Robert L. Findling	2015	64
5	Academic, Behavioral, and Cognitive Effects of OROS ^® Methylphenidate on Older Children with Attention-Deficit/Hyperactivity Disorder Journal of Child and Adolescent Psychopharmacology ·Sharon B. Wigal, Tim Wigal, Sabrina Schuck, Matthew Brams, David J. Williamson, R. B. Armstrong, H. Lynn Starr	2011	50
6	Efficacy of Two Long-Acting Methylphenidate Formulations in Children with Attention- Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting Journal of Child and Adolescent Psychopharmacology ·Raul Silva, Rafael Muniz, Linda Pestreich, Matthew Brams, Ann Childress, Frank A. López	2005	41
7	Efficacy and Duration of Effect of Extended-Release Dexmethylphenidate Versus Placebo in Schoolchildren With Attention-Deficit/Hyperactivity Disorder Journal of Child and Adolescent Psychopharmacology ·Raul R. Silva, Rafael Muniz, Linda Pestreich, Ann Childress, Matthew Brams, Frank A. López, James Wang	2006	39
8	A Randomized, Double-Blind, Crossover Study of Once-Daily Dexmethylphenidate in Children with Attention-Deficit Hyperactivity Disorder CNS Drugs ·Matthew Brams, Rafael Muniz, Ann Childress, John Giblin, Alice R. Mao, John M. Turnbow, Mary Borrello, (unknown), Frank A. López, Raul Silva	2008	37
9	Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder The Journal of Clinical Psychiatry ·Matthew Brams, Richard H. Weisler, Robert L. Findling, Maria Gasior, Mohamed Hamdani, M. Celeste Ferreira‐Cornwell, Liza Squires	2012	37
10	Efficacy and Safety of Extended-Release Dexmethylphenidate Compared with d,l -Methylphenidate and Placebo in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A 12-Hour Laboratory Classroom Study Journal of Child and Adolescent Psychopharmacology ·Rafael Muniz, Matthew Brams, Alice R. Mao, (unknown), Linda Pestreich, Raul Silva	2008	36
11	A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder Journal of Child and Adolescent Psychopharmacology ·Scott H. Kollins, Rene A. Braeckman, Sven Guenther, Andrew C. Barrett, Travis Mickle, Charles Oh, Andrea Marraffino, Andrew J. Cutler, Matthew Brams	2021	27
12	Open-Label Administration of Lisdexamfetamine Dimesylate Improves Executive Function Impairments and Symptoms of Attention-Deficit/Hyperactivity Disorder in Adults Postgraduate Medicine ·Thomas E. Brown, Matthew Brams, Joseph Gao, Maria Gasior, Ann Childress	2010	27
13	Duration of effect of oral long-acting stimulant medications for ADHD throughout the day Current Medical Research and Opinion ·Matthew Brams, Eliot Moon, Michael L. Pucci, Frank A. López	2010	25
14	Dexmethylphenidate ExtendeD-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder Journal of the American Academy of Child & Adolescent Psychiatry ·Raul R. Silva, Rafael Muniz, Linda Pestreich, Matthew Brams, Alice R. Mao, Ann Childress, James Wang	2008	24
15	The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study Journal of Child and Adolescent Psychopharmacology ·Ann Childress, Matthew Brams, Andrew J. Cutler, Scott H. Kollins, Jo Northcutt, Americo Padilla, John M. Turnbow	2015	23
16	A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings Journal of Child and Adolescent Psychopharmacology ·Ann Childress, Andrew J. Cutler, Andrea Marraffino, Mary Ann McDonnell, John M. Turnbow, Matthew Brams, Norberto J. DeSousa, Bev Incledon, Floyd R. Sallee, Sharon B. Wigal	2019	21
17	Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults Current Medical Research and Opinion ·Thomas E. Brown, Matthew Brams, Maria Gasior, Ben Adeyi, T. Babcock, Bryan Dirks, Brian Scheckner, Timothy Wigal	2011	20
18	Response/Remission With Guanfacine Extended-Release and Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Journal of the American Academy of Child & Adolescent Psychiatry ·Andrew J. Cutler, Matthew Brams, Oscar G. Bukstein, Gregory W. Mattingly, Keith McBurnett, Carla White, Jonathan Rubin	2014	19
19	Onset of Efficacy of Long-Acting Psychostimulants in Pediatric Attention-Deficit/Hyperactivity Disorder Postgraduate Medicine ·Matthew Brams, Alice R. Mao, Robert Doyle	2008	19
20	Changes in Emotions Related to Medication Used to Treat ADHD. Part I: Literature Review Journal of Attention Disorders ·Michael J. Manos, Matthew Brams, Ann Childress, Robert L. Findling, Frank A. López, Peter S. Jensen	2010	19

About Matthew Brams

Matthew Brams is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience, Developmental and Educational Psychology, Clinical Psychology and Pharmacology, having authored 40 papers that have together received 995 indexed citations. Recurring topics across this work include Attention Deficit Hyperactivity Disorder (35 papers), Bipolar Disorder and Treatment (18 papers), Child and Adolescent Psychosocial and Emotional Development (9 papers), Behavioral and Psychological Studies (6 papers), Autism Spectrum Disorder Research (5 papers), Functional Brain Connectivity Studies (4 papers), Neural and Behavioral Psychology Studies (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Psychiatry and Mental health (915 citations), Cognitive Neuroscience (400 citations), Developmental and Educational Psychology (166 citations), Clinical Psychology (193 citations) and Pharmacology (92 citations). Matthew Brams has collaborated with scholars based in United States, Switzerland and Belgium. Frequent co-authors include Ann Childress, Maria Gasior, Robert L. Findling, Rafael Muniz, Joseph Gao, Timothy Wigal, Alice R. Mao, Sharon B. Wigal, Linda Pestreich and Frank A. López. Their work appears in journals such as Journal of Child and Adolescent Psychopharmacology, Journal of the American Academy of Child & Adolescent Psychiatry, Journal of Attention Disorders, Current Medical Research and Opinion and The Journal of Clinical Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact